Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Wuxi Biologics (Cayman) ( (HK:2269) ) just unveiled an announcement.
WuXi Biologics (Cayman) Inc. has announced a board meeting scheduled for March 25, 2025, to discuss and approve the annual results for the year ending December 31, 2024. This meeting is significant for evaluating the company’s financial performance and strategizing future operations, impacting its market positioning and stakeholder interests.
More about Wuxi Biologics (Cayman)
WuXi Biologics (Cayman) Inc. operates in the biopharmaceutical industry, providing end-to-end solutions for biologics discovery, development, and manufacturing. The company focuses on accelerating and transforming how biologics are developed and manufactured globally.
YTD Price Performance: 34.72%
Average Trading Volume: 6,070
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $13.74B
Find detailed analytics on 2269 stock on TipRanks’ Stock Analysis page.